2,4-thiazolidinedione

DB11898InvestigationalSmall molecule

Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2.

Chemical structure of 2,4-thiazolidinedione
Formula / weight
C3H3NO2S · 117.12 g/mol (avg)
Also known as
Thiazolidinedione
Code names
NSC-6745

Resolves to

Compound
UNIIAA68LXK93CCAS2295-31-0ChEMBLCHEMBL85398ChEBI50992PubChem5437
Structure
InChIKeyZOBPZXTWZATXDG-UHFFFAOYSA-NSMILESO=C1CSC(=O)N1
Targets
P37231PPARG

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
608Drug interactionsStructured to mechanism, not free text
Sign in
13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with 2,4-thiazolidinedione, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In